CVS Health Current Valuation

CVS Health Corporation -- USA Stock  

USD 68.76  0.60  0.88%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Current Valuation Analysis

Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CVS Health 
Enterprise Value 
Market Cap + Debt 
98.16 B

Distress Driver Correlations

 CVS Health Enterprise Value 

About Current Valuation

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition


CVS Health Income Change Over Time

Accumulated Other Comprehensive Income

In accordance with recently published financial statements CVS Health Corporation has Current Valuation of 98.16 B. This is 80.27% higher than that of the Healthcare sector, and significantly higher than that of Healthcare Services industry, The Current Valuation for all stocks is 35.48% higher than the company.

Peer Comparison

CVS Health Current Valuation Comparison
  Current Valuation 
      CVS Health Comparables 
CVS Health is the top company in current valuation category among related companies.

Did you try this?

Run Efficient Frontier Now

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
Hide  View All  NextLaunch Efficient Frontier